NO20044092L - Oftalmisk sammensetning som innbefatter ascomycin - Google Patents

Oftalmisk sammensetning som innbefatter ascomycin

Info

Publication number
NO20044092L
NO20044092L NO20044092A NO20044092A NO20044092L NO 20044092 L NO20044092 L NO 20044092L NO 20044092 A NO20044092 A NO 20044092A NO 20044092 A NO20044092 A NO 20044092A NO 20044092 L NO20044092 L NO 20044092L
Authority
NO
Norway
Prior art keywords
ascomycin
composition including
ophthalmic composition
ophthalmic
including ascomycin
Prior art date
Application number
NO20044092A
Other languages
English (en)
Norwegian (no)
Inventor
Shau-Fong Yen
Michelle Pik-Han Wong
Maggy Babiole Saunier
Jean-Claude Bizec
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044092(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044092L publication Critical patent/NO20044092L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20044092A 2002-03-04 2004-09-27 Oftalmisk sammensetning som innbefatter ascomycin NO20044092L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US40927502P 2002-09-09 2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en) 2002-03-04 2003-03-03 Ophthalmic composition comprising ascomycin

Publications (1)

Publication Number Publication Date
NO20044092L true NO20044092L (no) 2004-09-27

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044092A NO20044092L (no) 2002-03-04 2004-09-27 Oftalmisk sammensetning som innbefatter ascomycin

Country Status (28)

Country Link
US (4) US20050220823A1 (es)
EP (1) EP1482936B1 (es)
JP (1) JP4740542B2 (es)
KR (1) KR100992948B1 (es)
CN (1) CN1297270C (es)
AR (1) AR038628A1 (es)
AT (1) ATE341326T1 (es)
AU (1) AU2003218679B2 (es)
BR (1) BR0308184A (es)
CA (1) CA2477769C (es)
CO (1) CO5611133A2 (es)
DE (1) DE60308836T2 (es)
DK (1) DK1482936T3 (es)
EC (1) ECSP045277A (es)
EG (1) EG24403A (es)
ES (1) ES2274214T3 (es)
HK (1) HK1071301A1 (es)
IL (2) IL163657A0 (es)
MX (1) MXPA04008571A (es)
MY (1) MY137563A (es)
NO (1) NO20044092L (es)
NZ (1) NZ534690A (es)
PE (1) PE20030828A1 (es)
PL (1) PL210870B1 (es)
PT (1) PT1482936E (es)
RU (1) RU2322982C2 (es)
TW (1) TW200305437A (es)
WO (1) WO2003074054A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100355455C (zh) 2002-07-15 2007-12-19 爱尔康公司 用于眼内使用的非聚合亲脂性药物植入组合物
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en) 2009-04-09 2010-10-13 Nestec S.A. Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
BRPI1010907B8 (pt) 2009-05-12 2021-05-25 Galenica Ab emulsão de óleo-em-água de mometasona e propileno-glicol
BR112012014499A2 (pt) * 2009-12-22 2016-08-16 Abbott Lab cápsula de abt-263
CN102883708A (zh) * 2010-04-07 2013-01-16 阿勒根公司 用于眼用组合物的防腐剂联合
RU2531937C2 (ru) * 2012-05-14 2014-10-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазной мази
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
WO2014153733A1 (en) * 2013-03-27 2014-10-02 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
WO2015080249A1 (ja) * 2013-11-29 2015-06-04 ロート製薬株式会社 眼科用又は耳鼻科用水性組成物
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en) * 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
WO2024159768A1 (zh) * 2023-01-31 2024-08-08 温士顿医药股份有限公司 一种滴眼油剂型的医药组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66485B1 (en) * 1989-07-05 1996-01-10 Fujisawa Pharmaceutical Co Aqueous liquid composition for external use
EP0474126B1 (en) * 1990-09-04 1997-03-19 Fujisawa Pharmaceutical Co., Ltd. Ointments containing tricyclic compound
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
DE69328368T2 (de) * 1992-08-28 2000-08-10 Pharmos Corp., New York Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
EP0664705B1 (en) * 1993-08-18 2000-10-04 Alcon Laboratories, Inc. Compositions of ergoline derivatives for the treatment of glaucoma
WO1996011003A1 (en) * 1994-10-10 1996-04-18 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
JP4155593B2 (ja) * 1994-10-26 2008-09-24 ノバルティス・アクチエンゲゼルシャフト 医薬組成物
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
AU749475B2 (en) * 1998-04-27 2002-06-27 Astellas Pharma Inc. Medicinal compositions
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
CN1190194C (zh) * 1999-04-30 2005-02-23 苏坎波公司 用于治疗干眼的大环内酯化合物的应用

Also Published As

Publication number Publication date
CN1297270C (zh) 2007-01-31
RU2322982C2 (ru) 2008-04-27
US20100113501A1 (en) 2010-05-06
CN1638769A (zh) 2005-07-13
JP4740542B2 (ja) 2011-08-03
AU2003218679B2 (en) 2007-04-05
TW200305437A (en) 2003-11-01
PL210870B1 (pl) 2012-03-30
PT1482936E (pt) 2007-01-31
WO2003074054A1 (en) 2003-09-12
PL370917A1 (en) 2005-06-13
IL163657A0 (en) 2005-12-18
MXPA04008571A (es) 2004-12-06
CA2477769C (en) 2011-01-18
DE60308836T2 (de) 2007-04-26
DE60308836D1 (de) 2006-11-16
JP2005529851A (ja) 2005-10-06
CA2477769A1 (en) 2003-09-12
PE20030828A1 (es) 2003-11-04
ATE341326T1 (de) 2006-10-15
US20110152307A1 (en) 2011-06-23
EP1482936A1 (en) 2004-12-08
KR20040094718A (ko) 2004-11-10
RU2004129593A (ru) 2005-09-10
US20120015971A1 (en) 2012-01-19
ECSP045277A (es) 2004-10-26
KR100992948B1 (ko) 2010-11-08
HK1071301A1 (en) 2005-07-15
MY137563A (en) 2009-02-27
US20050220823A1 (en) 2005-10-06
EP1482936B1 (en) 2006-10-04
AU2003218679A1 (en) 2003-09-16
ES2274214T3 (es) 2007-05-16
CO5611133A2 (es) 2006-02-28
EG24403A (en) 2009-04-29
IL163657A (en) 2009-11-18
BR0308184A (pt) 2005-01-11
AR038628A1 (es) 2005-01-19
DK1482936T3 (da) 2007-01-08
NZ534690A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
NO20040775L (no) Oftalmisk sammensetning som innbefatter et askomycin
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DE60312054D1 (de) Prothese
DE602004031845D1 (de) Ng
HK1071301A1 (en) Ophthalmic composition comprising ascomycin
DE10393374D2 (de) Zusammensetzung
BRPI0313075A2 (pt) composições de vidro
SE0500163L (sv) Sammansättning
DE60306259D1 (de) Auswuchtgerät
DK1492934T3 (da) Dørenhed
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
DE60322421D1 (de) Verbesserter brillenbügel
DE60236403D1 (de) Tourbillonmechanismus
DE602004018799D1 (de) Ng
EP1661573A4 (en) OPHTHALMIC COMPOSITION
DE50307217D1 (de) Glaskörper
DE60328488D1 (de) Ng
EP1647273A4 (en) OPHTHALMIC COMPOSITION
ITMI20031187A0 (it) Astuccio per occhiali
NO20044140D0 (no) New Composition
DE60333472D1 (de) Kautschukzusammensetzung
ITMI20021327A1 (it) Nuove ossialchilpiperazine
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.
ITUD20020023U1 (it) Cerniera per occhiali
SI1482936T1 (sl) Oftalmicni sestavek, ki vkljucuje askomicin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application